APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gabapentin Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Gabapentin Drug Industry Research Report 2026

Report ID 173993750520 December 2025150 pages

Choose your research edition.

Industry ResearchGabapentin Drug Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Gabapentin Drug Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Gabapentin Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gabapentin Drug Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Gabapentin Drug Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Gabapentin Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Gabapentin Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Gabapentin Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Gabapentin Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Gabapentin Drug include Teva, Sun Pharmaceutical, Mylan, Pfizer, Zydus Pharmaceuticals, Tris Pharma, Taro, Sciegen Pharmaceuticals and Marksans Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Gabapentin Drug market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Gabapentin Drug Market by Company

Teva

Sun Pharmaceutical

Mylan

Pfizer

Zydus Pharmaceuticals

Tris Pharma

Taro

Sciegen Pharmaceuticals

Marksans Pharma

Lupin Limited

Jiangsu Hengrui Medicine

InvaGen Pharmaceuticals

Hi-Tech Pharmaceuticals

Glenmark

Epic Pharma

Depomed

CSPC Ouyi Pharmaceutical

Aurobindo Pharma

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

ACI HealthCare Limited

Acella Pharmaceuticals

Gabapentin Drug Segment by Type

Capsule

Oral Solution

Tablet

Gabapentin Drug Segment by Application

Postherpetic Neuralgia in Adults

Partial Onset Seizures

Others

Gabapentin Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gabapentin Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gabapentin Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gabapentin Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Gabapentin Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Gabapentin Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Gabapentin Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gabapentin Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Gabapentin Drug Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Gabapentin Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Gabapentin Drug Revenue of Manufacturers (2021-2026) Table 9. Global Gabapentin Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Gabapentin Drug Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Gabapentin Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Gabapentin Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Gabapentin Drug, Product Type & Application Table 14. Global Gabapentin Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Gabapentin Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Company Information Table 19. Teva Business Overview Table 20. Teva Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Teva Gabapentin Drug Product Portfolio Table 22. Teva Recent Developments Table 23. Sun Pharmaceutical Company Information Table 24. Sun Pharmaceutical Business Overview Table 25. Sun Pharmaceutical Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Sun Pharmaceutical Gabapentin Drug Product Portfolio Table 27. Sun Pharmaceutical Recent Developments Table 28. Mylan Company Information Table 29. Mylan Business Overview Table 30. Mylan Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Mylan Gabapentin Drug Product Portfolio Table 32. Mylan Recent Developments Table 33. Pfizer Company Information Table 34. Pfizer Business Overview Table 35. Pfizer Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Pfizer Gabapentin Drug Product Portfolio Table 37. Pfizer Recent Developments Table 38. Zydus Pharmaceuticals Company Information Table 39. Zydus Pharmaceuticals Business Overview Table 40. Zydus Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Zydus Pharmaceuticals Gabapentin Drug Product Portfolio Table 42. Zydus Pharmaceuticals Recent Developments Table 43. Tris Pharma Company Information Table 44. Tris Pharma Business Overview Table 45. Tris Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Tris Pharma Gabapentin Drug Product Portfolio Table 47. Tris Pharma Recent Developments Table 48. Taro Company Information Table 49. Taro Business Overview Table 50. Taro Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Taro Gabapentin Drug Product Portfolio Table 52. Taro Recent Developments Table 53. Sciegen Pharmaceuticals Company Information Table 54. Sciegen Pharmaceuticals Business Overview Table 55. Sciegen Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio Table 57. Sciegen Pharmaceuticals Recent Developments Table 58. Marksans Pharma Company Information Table 59. Marksans Pharma Business Overview Table 60. Marksans Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Marksans Pharma Gabapentin Drug Product Portfolio Table 62. Marksans Pharma Recent Developments Table 63. Lupin Limited Company Information Table 64. Lupin Limited Business Overview Table 65. Lupin Limited Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lupin Limited Gabapentin Drug Product Portfolio Table 67. Lupin Limited Recent Developments Table 68. Jiangsu Hengrui Medicine Company Information Table 69. Jiangsu Hengrui Medicine Business Overview Table 70. Jiangsu Hengrui Medicine Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio Table 72. Jiangsu Hengrui Medicine Recent Developments Table 73. InvaGen Pharmaceuticals Company Information Table 74. InvaGen Pharmaceuticals Business Overview Table 75. InvaGen Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio Table 77. InvaGen Pharmaceuticals Recent Developments Table 78. Hi-Tech Pharmaceuticals Company Information Table 79. Hi-Tech Pharmaceuticals Business Overview Table 80. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio Table 82. Hi-Tech Pharmaceuticals Recent Developments Table 83. Glenmark Company Information Table 84. Glenmark Business Overview Table 85. Glenmark Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Glenmark Gabapentin Drug Product Portfolio Table 87. Glenmark Recent Developments Table 88. Epic Pharma Company Information Table 89. Epic Pharma Business Overview Table 90. Epic Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Epic Pharma Gabapentin Drug Product Portfolio Table 92. Epic Pharma Recent Developments Table 93. Depomed Company Information Table 94. Depomed Business Overview Table 95. Depomed Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Depomed Gabapentin Drug Product Portfolio Table 97. Depomed Recent Developments Table 98. CSPC Ouyi Pharmaceutical Company Information Table 99. CSPC Ouyi Pharmaceutical Business Overview Table 100. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio Table 102. CSPC Ouyi Pharmaceutical Recent Developments Table 103. Aurobindo Pharma Company Information Table 104. Aurobindo Pharma Business Overview Table 105. Aurobindo Pharma Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Aurobindo Pharma Gabapentin Drug Product Portfolio Table 107. Aurobindo Pharma Recent Developments Table 108. Apotex Company Information Table 109. Apotex Business Overview Table 110. Apotex Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Apotex Gabapentin Drug Product Portfolio Table 112. Apotex Recent Developments Table 113. Amneal Pharmaceuticals Company Information Table 114. Amneal Pharmaceuticals Business Overview Table 115. Amneal Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Amneal Pharmaceuticals Gabapentin Drug Product Portfolio Table 117. Amneal Pharmaceuticals Recent Developments Table 118. Alkem Laboratories Company Information Table 119. Alkem Laboratories Business Overview Table 120. Alkem Laboratories Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Alkem Laboratories Gabapentin Drug Product Portfolio Table 122. Alkem Laboratories Recent Developments Table 123. ACI HealthCare Limited Company Information Table 124. ACI HealthCare Limited Business Overview Table 125. ACI HealthCare Limited Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. ACI HealthCare Limited Gabapentin Drug Product Portfolio Table 127. ACI HealthCare Limited Recent Developments Table 128. Acella Pharmaceuticals Company Information Table 129. Acella Pharmaceuticals Business Overview Table 130. Acella Pharmaceuticals Gabapentin Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Acella Pharmaceuticals Gabapentin Drug Product Portfolio Table 132. Acella Pharmaceuticals Recent Developments Table 133. Global Gabapentin Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Gabapentin Drug Sales by Region (2021-2026) & (W Units) Table 135. Global Gabapentin Drug Sales Market Share by Region (2021-2026) Table 136. Global Gabapentin Drug Sales by Region (2027-2032) & (W Units) Table 137. Global Gabapentin Drug Sales Market Share by Region (2027-2032) Table 138. Global Gabapentin Drug Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Gabapentin Drug Revenue Market Share by Region (2021-2026) Table 140. Global Gabapentin Drug Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Gabapentin Drug Revenue Market Share by Region (2027-2032) Table 142. North America Gabapentin Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 144. North America Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 145. North America Gabapentin Drug Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Gabapentin Drug Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Gabapentin Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 149. Europe Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 150. Europe Gabapentin Drug Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Gabapentin Drug Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Gabapentin Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 154. Asia Pacific Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 155. Asia Pacific Gabapentin Drug Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Gabapentin Drug Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Gabapentin Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 159. South America Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 160. South America Gabapentin Drug Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Gabapentin Drug Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Gabapentin Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Gabapentin Drug Sales by Country (2021-2026) & (W Units) Table 164. Middle East and Africa Gabapentin Drug Sales by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Gabapentin Drug Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Gabapentin Drug Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Gabapentin Drug Sales by Type (2021-2026) & (W Units) Table 168. Global Gabapentin Drug Sales by Type (2027-2032) & (W Units) Table 169. Global Gabapentin Drug Sales Market Share by Type (2021-2026) Table 170. Global Gabapentin Drug Sales Market Share by Type (2027-2032) Table 171. Global Gabapentin Drug Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Gabapentin Drug Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Gabapentin Drug Revenue Market Share by Type (2021-2026) Table 174. Global Gabapentin Drug Revenue Market Share by Type (2027-2032) Table 175. Global Gabapentin Drug Price by Type (2021-2026) & (US$/Unit) Table 176. Global Gabapentin Drug Price by Type (2027-2032) & (US$/Unit) Table 177. Global Gabapentin Drug Sales by Application (2021-2026) & (W Units) Table 178. Global Gabapentin Drug Sales by Application (2027-2032) & (W Units) Table 179. Global Gabapentin Drug Sales Market Share by Application (2021-2026) Table 180. Global Gabapentin Drug Sales Market Share by Application (2027-2032) Table 181. Global Gabapentin Drug Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Gabapentin Drug Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Gabapentin Drug Revenue Market Share by Application (2021-2026) Table 184. Global Gabapentin Drug Revenue Market Share by Application (2027-2032) Table 185. Global Gabapentin Drug Price by Application (2021-2026) & (US$/Unit) Table 186. Global Gabapentin Drug Price by Application (2027-2032) & (US$/Unit) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Gabapentin Drug Distributors List Table 190. Gabapentin Drug Customers List Table 191. Gabapentin Drug Industry Trends Table 192. Gabapentin Drug Industry Drivers Table 193. Gabapentin Drug Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Gabapentin Drug Product Image Figure 5. Global Gabapentin Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Gabapentin Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Gabapentin Drug Sales (2021-2032) & (W Units) Figure 8. Global Gabapentin Drug Average Price (US$/Unit) & (2021-2032) Figure 9. Capsule Product Image Figure 10. Oral Solution Product Image Figure 11. Tablet Product Image Figure 12. Postherpetic Neuralgia in Adults Product Image Figure 13. Partial Onset Seizures Product Image Figure 14. Others Product Image Figure 15. Global Gabapentin Drug Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Gabapentin Drug, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Gabapentin Drug Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gabapentin Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Gabapentin Drug Sales by Region in 2025 Figure 21. Global Gabapentin Drug Revenue by Region in 2025 Figure 22. North America Gabapentin Drug Market Size by Country in 2025 Figure 23. North America Gabapentin Drug Sales Market Share by Country (2021-2032) Figure 24. North America Gabapentin Drug Revenue Market Share by Country (2021-2032) Figure 25. United States Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Gabapentin Drug Market Size by Country in 2025 Figure 28. Europe Gabapentin Drug Sales Market Share by Country (2021-2032) Figure 29. Europe Gabapentin Drug Revenue Market Share by Country (2021-2032) Figure 30. Germany Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Gabapentin Drug Market Size by Country in 2025 Figure 36. Asia Pacific Gabapentin Drug Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Gabapentin Drug Revenue Market Share by Country (2021-2032) Figure 38. China Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Gabapentin Drug Market Size by Country in 2025 Figure 47. South America Gabapentin Drug Sales Market Share by Country (2021-2032) Figure 48. South America Gabapentin Drug Revenue Market Share by Country (2021-2032) Figure 49. Mexico Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Gabapentin Drug Market Size by Country in 2025 Figure 53. Middle East and Africa Gabapentin Drug Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Gabapentin Drug Revenue Market Share by Country (2021-2032) Figure 55. Turkey Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Gabapentin Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Gabapentin Drug Sales Market Share by Type (2021-2032) Figure 59. Global Gabapentin Drug Revenue Market Share by Type (2021-2032) Figure 60. Global Gabapentin Drug Price (US$/Unit) by Type (2021-2032) Figure 61. Global Gabapentin Drug Sales Market Share by Application (2021-2032) Figure 62. Global Gabapentin Drug Revenue Market Share by Application (2021-2032) Figure 63. Global Gabapentin Drug Price (US$/Unit) by Application (2021-2032) Figure 64. Gabapentin Drug Value Chain Figure 65. Gabapentin Drug Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Gabapentin Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Capsule
  • Oral Solution
  • Tablet
Applications
  • Postherpetic Neuralgia in Adults
  • Partial Onset Seizures
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Mylan
  • Pfizer
  • Zydus Pharmaceuticals
  • Tris Pharma
  • Taro
  • Sciegen Pharmaceuticals
  • Marksans Pharma
  • Lupin Limited
  • Jiangsu Hengrui Medicine
  • InvaGen Pharmaceuticals
  • Hi-Tech Pharmaceuticals
  • Glenmark
  • Epic Pharma
  • Depomed
  • CSPC Ouyi Pharmaceutical
  • Aurobindo Pharma
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories
  • ACI HealthCare Limited
  • Acella Pharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Gabapentin Drug Market Size (2021-2032)
  4. 2.2.2 Global Gabapentin Drug Sales (2021-2032)
  5. 2.2.3 Global Gabapentin Drug Market Average Price (2021-2032)
  6. 2.3 Gabapentin Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Capsule
  9. 2.3.3 Oral Solution
  10. 2.3.4 Tablet
  11. 2.4 Gabapentin Drug by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Postherpetic Neuralgia in Adults
  14. 2.4.3 Partial Onset Seizures
  15. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Gabapentin Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Gabapentin Drug Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Gabapentin Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Gabapentin Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Gabapentin Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Gabapentin Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Gabapentin Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Gabapentin Drug, Established Date
  9. 3.9 Global Gabapentin Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva
  2. 4.1.1 Teva Company Information
  3. 4.1.2 Teva Business Overview
  4. 4.1.3 Teva Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Gabapentin Drug Product Portfolio
  6. 4.1.5 Teva Recent Developments
  7. 4.2 Sun Pharmaceutical
  8. 4.2.1 Sun Pharmaceutical Company Information
  9. 4.2.2 Sun Pharmaceutical Business Overview
  10. 4.2.3 Sun Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sun Pharmaceutical Gabapentin Drug Product Portfolio
  12. 4.2.5 Sun Pharmaceutical Recent Developments
  13. 4.3 Mylan
  14. 4.3.1 Mylan Company Information
  15. 4.3.2 Mylan Business Overview
  16. 4.3.3 Mylan Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Mylan Gabapentin Drug Product Portfolio
  18. 4.3.5 Mylan Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Company Information
  21. 4.4.2 Pfizer Business Overview
  22. 4.4.3 Pfizer Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Gabapentin Drug Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 Zydus Pharmaceuticals
  26. 4.5.1 Zydus Pharmaceuticals Company Information
  27. 4.5.2 Zydus Pharmaceuticals Business Overview
  28. 4.5.3 Zydus Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Zydus Pharmaceuticals Gabapentin Drug Product Portfolio
  30. 4.5.5 Zydus Pharmaceuticals Recent Developments
  31. 4.6 Tris Pharma
  32. 4.6.1 Tris Pharma Company Information
  33. 4.6.2 Tris Pharma Business Overview
  34. 4.6.3 Tris Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Tris Pharma Gabapentin Drug Product Portfolio
  36. 4.6.5 Tris Pharma Recent Developments
  37. 4.7 Taro
  38. 4.7.1 Taro Company Information
  39. 4.7.2 Taro Business Overview
  40. 4.7.3 Taro Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Taro Gabapentin Drug Product Portfolio
  42. 4.7.5 Taro Recent Developments
  43. 4.8 Sciegen Pharmaceuticals
  44. 4.8.1 Sciegen Pharmaceuticals Company Information
  45. 4.8.2 Sciegen Pharmaceuticals Business Overview
  46. 4.8.3 Sciegen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sciegen Pharmaceuticals Gabapentin Drug Product Portfolio
  48. 4.8.5 Sciegen Pharmaceuticals Recent Developments
  49. 4.9 Marksans Pharma
  50. 4.9.1 Marksans Pharma Company Information
  51. 4.9.2 Marksans Pharma Business Overview
  52. 4.9.3 Marksans Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Marksans Pharma Gabapentin Drug Product Portfolio
  54. 4.9.5 Marksans Pharma Recent Developments
  55. 4.10 Lupin Limited
  56. 4.10.1 Lupin Limited Company Information
  57. 4.10.2 Lupin Limited Business Overview
  58. 4.10.3 Lupin Limited Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Lupin Limited Gabapentin Drug Product Portfolio
  60. 4.10.5 Lupin Limited Recent Developments
  61. 4.11 Jiangsu Hengrui Medicine
  62. 4.11.1 Jiangsu Hengrui Medicine Company Information
  63. 4.11.2 Jiangsu Hengrui Medicine Business Overview
  64. 4.11.3 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Jiangsu Hengrui Medicine Gabapentin Drug Product Portfolio
  66. 4.11.5 Jiangsu Hengrui Medicine Recent Developments
  67. 4.12 InvaGen Pharmaceuticals
  68. 4.12.1 InvaGen Pharmaceuticals Company Information
  69. 4.12.2 InvaGen Pharmaceuticals Business Overview
  70. 4.12.3 InvaGen Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 InvaGen Pharmaceuticals Gabapentin Drug Product Portfolio
  72. 4.12.5 InvaGen Pharmaceuticals Recent Developments
  73. 4.13 Hi-Tech Pharmaceuticals
  74. 4.13.1 Hi-Tech Pharmaceuticals Company Information
  75. 4.13.2 Hi-Tech Pharmaceuticals Business Overview
  76. 4.13.3 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hi-Tech Pharmaceuticals Gabapentin Drug Product Portfolio
  78. 4.13.5 Hi-Tech Pharmaceuticals Recent Developments
  79. 4.14 Glenmark
  80. 4.14.1 Glenmark Company Information
  81. 4.14.2 Glenmark Business Overview
  82. 4.14.3 Glenmark Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Glenmark Gabapentin Drug Product Portfolio
  84. 4.14.5 Glenmark Recent Developments
  85. 4.15 Epic Pharma
  86. 4.15.1 Epic Pharma Company Information
  87. 4.15.2 Epic Pharma Business Overview
  88. 4.15.3 Epic Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Epic Pharma Gabapentin Drug Product Portfolio
  90. 4.15.5 Epic Pharma Recent Developments
  91. 4.16 Depomed
  92. 4.16.1 Depomed Company Information
  93. 4.16.2 Depomed Business Overview
  94. 4.16.3 Depomed Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Depomed Gabapentin Drug Product Portfolio
  96. 4.16.5 Depomed Recent Developments
  97. 4.17 CSPC Ouyi Pharmaceutical
  98. 4.17.1 CSPC Ouyi Pharmaceutical Company Information
  99. 4.17.2 CSPC Ouyi Pharmaceutical Business Overview
  100. 4.17.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Product Portfolio
  102. 4.17.5 CSPC Ouyi Pharmaceutical Recent Developments
  103. 4.18 Aurobindo Pharma
  104. 4.18.1 Aurobindo Pharma Company Information
  105. 4.18.2 Aurobindo Pharma Business Overview
  106. 4.18.3 Aurobindo Pharma Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Aurobindo Pharma Gabapentin Drug Product Portfolio
  108. 4.18.5 Aurobindo Pharma Recent Developments
  109. 4.19 Apotex
  110. 4.19.1 Apotex Company Information
  111. 4.19.2 Apotex Business Overview
  112. 4.19.3 Apotex Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Apotex Gabapentin Drug Product Portfolio
  114. 4.19.5 Apotex Recent Developments
  115. 4.20 Amneal Pharmaceuticals
  116. 4.20.1 Amneal Pharmaceuticals Company Information
  117. 4.20.2 Amneal Pharmaceuticals Business Overview
  118. 4.20.3 Amneal Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Amneal Pharmaceuticals Gabapentin Drug Product Portfolio
  120. 4.20.5 Amneal Pharmaceuticals Recent Developments
  121. 4.21 Alkem Laboratories
  122. 4.21.1 Alkem Laboratories Company Information
  123. 4.21.2 Alkem Laboratories Business Overview
  124. 4.21.3 Alkem Laboratories Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Alkem Laboratories Gabapentin Drug Product Portfolio
  126. 4.21.5 Alkem Laboratories Recent Developments
  127. 4.22 ACI HealthCare Limited
  128. 4.22.1 ACI HealthCare Limited Company Information
  129. 4.22.2 ACI HealthCare Limited Business Overview
  130. 4.22.3 ACI HealthCare Limited Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 ACI HealthCare Limited Gabapentin Drug Product Portfolio
  132. 4.22.5 ACI HealthCare Limited Recent Developments
  133. 4.23 Acella Pharmaceuticals
  134. 4.23.1 Acella Pharmaceuticals Company Information
  135. 4.23.2 Acella Pharmaceuticals Business Overview
  136. 4.23.3 Acella Pharmaceuticals Gabapentin Drug Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Acella Pharmaceuticals Gabapentin Drug Product Portfolio
  138. 4.23.5 Acella Pharmaceuticals Recent Developments
5 Global Gabapentin Drug Market Scenario by Region
  1. 5.1 Global Gabapentin Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Gabapentin Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Gabapentin Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Gabapentin Drug Sales by Region: 2027-2032
  5. 5.3 Global Gabapentin Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Gabapentin Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Gabapentin Drug Revenue by Region: 2027-2032
  8. 5.4 North America Gabapentin Drug Market Facts & Figures by Country
  9. 5.4.1 North America Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Gabapentin Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Gabapentin Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Gabapentin Drug Market Facts & Figures by Country
  15. 5.5.1 Europe Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Gabapentin Drug Sales by Country (2021-2032)
  17. 5.5.3 Europe Gabapentin Drug Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Gabapentin Drug Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Gabapentin Drug Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Gabapentin Drug Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Gabapentin Drug Market Facts & Figures by Country
  35. 5.7.1 South America Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Gabapentin Drug Sales by Country (2021-2032)
  37. 5.7.3 South America Gabapentin Drug Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Gabapentin Drug Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Gabapentin Drug Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Gabapentin Drug Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Gabapentin Drug Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Gabapentin Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Gabapentin Drug Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Gabapentin Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Gabapentin Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Gabapentin Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Gabapentin Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Gabapentin Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Gabapentin Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Gabapentin Drug Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Gabapentin Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Gabapentin Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Gabapentin Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Gabapentin Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Gabapentin Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Gabapentin Drug Value Chain Analysis
  2. 8.1.1 Gabapentin Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Gabapentin Drug Production Mode & Process
  5. 8.2 Gabapentin Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Gabapentin Drug Distributors
  8. 8.2.3 Gabapentin Drug Customers
9 Global Gabapentin Drug Analyzing Market Dynamics
  1. 9.1 Gabapentin Drug Industry Trends
  2. 9.2 Gabapentin Drug Industry Drivers
  3. 9.3 Gabapentin Drug Industry Opportunities and Challenges
  4. 9.4 Gabapentin Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst